Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (2,654)	$ 1,618	$ 9,515
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of capitalized software costs	22,571	23,016	20,108
Amortization and write-off of debt issuance costs	834	508	1,026
Amortization of other intangibles	9,035	12,397	21,109
Net amortization (accretion) of premiums/discounts on marketable securities	(476)
Change in fair value of contingent consideration	100	7	(1,367)
Deferred income taxes	(9,076)	215	(8,854)
Depreciation	5,088	6,902	7,997
Excess tax deficiency (benefit) from share-based compensation	(1,052)	643	798
Impairment of assets	3,163	3,906	5,539
Loss on disposal of equipment and improvements	90	97	12
Loss on foreign currency exchange rates	17
Non-cash operating lease costs	2,716	5,732	6,786
Provision for bad debts	1,914	1,915	2,834
Restructuring costs, net of amounts paid	1,990
Share-based compensation	33,458	26,552	22,710
Gain on disposition of Commercial Dental assets	(10,296)
Changes in assets and liabilities, net of amounts acquired:
Accounts receivable	(12,379)	(431)	(369)
Contract assets	5,930	(5,610)	(5,921)
Accounts payable	333	(2,329)	615
Contract liabilities	(6,739)	8,417	(3,923)
Accrued compensation and related benefits	(13,142)	(1,638)	26,582
Income taxes	2,790	(5,650)	1,615
Deferred compensation	803	610	1,320
Operating lease liabilities	(8,808)	(12,734)	(16,736)
Other assets and liabilities	17,450	(10,598)	7,122
Net cash provided by operating activities	43,660	53,545	98,518
Cash flows from investing activities:
Additions to capitalized software costs	(34,987)	(25,500)	(24,578)
Additions to equipment and improvements	(2,277)	(2,582)	(3,761)
Acquisition related working capital adjustment payments			(206)
Payments for acquisitions, net of cash acquired	(51,302)
Proceeds from disposition of Commercial Dental assets	11,253
Proceeds from sales of marketable securities	506
Purchases of marketable securities	(140,087)
Net cash used in investing activities	(216,894)	(28,082)	(28,545)
Cash flows from financing activities:
Proceeds from convertible senior notes	275,000
Proceeds from line of credit	50,000		50,000
Repayments on line of credit	(50,000)		(179,000)
Payment of debt issuance costs	(8,483)		(1,423)
Proceeds from issuance of shares under employee plans	6,835	5,014	3,479
Repurchase of common stock	(49,878)	(35,874)
Payment of contingent consideration related to acquisitions		(540)
Payments for taxes related to net share settlement of equity awards	(10,851)	(5,891)	(4,773)
Net cash provided by (used in) financing activities	212,623	(37,291)	(131,717)
Effect of exchange rate changes on cash and cash equivalents	(148)
Net increase (decrease) in cash, cash equivalents, and restricted cash	39,241	(11,828)	(61,744)
Cash, cash equivalents, and restricted cash at beginning of period	66,747	78,575	140,319
Cash, cash equivalents, and restricted cash at end of period	105,988	66,747	78,575
Supplemental disclosures of cash flow information:
Cash paid for income taxes	12,619	8,774	6,206
Cash refunds from income taxes	9	125	155
Cash paid for interest	1,190	573	2,708
Non-cash investing and financing activities:
Unrealized gain on marketable securities, net of $0 tax	42
Cash paid for amounts included in the measurement of operating lease liabilities	9,451	13,766	18,651
Operating lease assets obtained in exchange for operating lease liabilities	957	1,610	3,107
Accrued purchases of equipment and improvements	$ 800	$ 76	$ 242